LEX-WK-XG7KV4WBcrawled 2022-12-01 10:07Z
Failure-to-Warn Claim Targeting Branded Drug Held Preempted: Litigation-Driven Expert Analysis Is Not “Newly Acquired Information” for Purposes of the “Changes Being Effected” Regulation
Andrew Tauber · Drug & Device Law · Published September 19, 2022
Work details
- author
- Andrew Tauber
- firm or organization
- Drug & Device Law Blogging Team
- publication
- Drug & Device Law
- practice area
- Other
- published
- 2022-09-19
Citation
Andrew Tauber, Failure-to-Warn Claim Targeting Branded Drug Held Preempted: Litigation-Driven Expert Analysis Is Not “Newly Acquired Information” for Purposes of the “Changes Being Effected” Regulation, Drug & Device Law (September 19, 2022) [The Library at LexBlog, LEX-WK-XG7KV4WB, lexpid.org/XG7KV4WB]